chrisvoncsefalvay/vaers-outcomes huggingface dataset:
brain problems; cardiac problems; Bone pain; Muscle pain; Joint pain; This spontaneous case was reported by a patient and describes the occurrence of CEREBRAL DISORDER (brain problems), CARDIAC DISORDER (cardiac problems), BONE PAIN (Bone pain), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CEREBRAL DISORDER (brain problems), CARDIAC DISORDER (cardiac problems), BONE PAIN (Bone pain), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain). At the time of the report, CEREBRAL DISORDER (brain problems), CARDIAC DISORDER (cardiac problems), BONE PAIN (Bone pain), MYALGIA (Muscle pain) and ARTHRALGIA (Joint pain) had not resolved.            Concomitant medication was not reported. Patient still having adverse reactions to that shot (almost a year). Doctors don't know anything or refused to see the patient, the cardiac Doctor said that patient was one of the lucky one, they had saw people who was dead from it. Patient almost ready to try Ivermectin (the horse med).  Treatment drug was not reported.
have been sick; My husband had a fever for 3 days and can we possibly got the Covid from it.; This is a spontaneous report from a contactable consumer. This consumer reported similar events for 2 patients. This is 2nd of 2 reports. This consumer reported for a patient (Husband). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient have been sick and had a fever for 3 days and can we possibly got the COVID from it. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained.; Sender's Comments: Linked Report(s) : PFIZER INC-2021416198 Same reporter/diff patient.
pt recvd vax; 22oct94 devel fever; chills; sweat x 24 hrs; aches persisted; 24oct devel rash; denied arthralgias; 5 days prior to rash, exp rhinitis; headache; neck stiffeness ;
Pt had vaccine at 6:10, she was observed in the waiting area for 30 minutes with no adverse reactions. Pt was walking out to her car and stated she had trouble breathing and felt tingling in her face, hands and feet. Pt was brought back into the clinic and evaluated at 6:50. VS were within normal limits, pt did not have any difficulty breathing or noticeable swelling. No hives or rash was observed. Once seated in the clinic pt was given water and was able to calm down. Pt states her symptoms began to resolve but the numbness and tingling in her hands and feet persisted. Pt was advised to go to the nearest emergency room for further evaluation but pt declined and states she is comfortable going home.  Neuro exam was completed and no deficits were observed. She left the clinic with her fiance with instructions to go to the ER if symptoms did not improve or worsened.
On December 11, 2022 started having a cough, then a cough with blood and body temperature dropped to 86 degrees. Went to the emergency room and was admitted. Given a Chest X-ray and showed she had fluid in her lungs and was diagnosed with Pneumonia. Given a UTI test and was also positive. Tested for COVID-19 test and was negative. Was given antibiotics through IV and hospitalized for 10 days. Given Bi-pap treatments and Oxygen. Still on Oxygen at night. In Hospice.
spot was blotchy; spot was warm to touch; rashes on the surrounding; spot was itchy; spot was swollen; tenderness on the injection site for a couple of days; bit of a chill; Soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (spot was blotchy), VACCINATION SITE WARMTH (spot was warm to touch), RASH (rashes on the surrounding), VACCINATION SITE PRURITUS (spot was itchy) and CHILLS (bit of a chill) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced CHILLS (bit of a chill), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE PAIN (tenderness on the injection site for a couple of days). On 01-May-2021, the patient experienced RASH MACULAR (spot was blotchy), VACCINATION SITE WARMTH (spot was warm to touch), RASH (rashes on the surrounding), VACCINATION SITE PRURITUS (spot was itchy) and VACCINATION SITE SWELLING (spot was swollen). At the time of the report, RASH MACULAR (spot was blotchy), VACCINATION SITE WARMTH (spot was warm to touch), RASH (rashes on the surrounding), VACCINATION SITE PRURITUS (spot was itchy), CHILLS (bit of a chill), VACCINATION SITE PAIN (Soreness at the injection site), VACCINATION SITE SWELLING (spot was swollen) and VACCINATION SITE PAIN (tenderness on the injection site for a couple of days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information for the events was provided.  Patient  reported she would be going to see her primary healthcare physician the day after the report was given.
Jan. 4, 2021  First day of vaccine administration , slight soreness at injection site in the evening. Jan. 5, 2021  4:00 PM  Arm pit soreness, both arms. Injection site ok. Jan. 6, 2021   4:00 AM Injection site soreness, strong aching in neck, shoulders, and across upper back .Continued armpit soreness, both        arms. Felt neck and throat and discovered swollen lymph nodes. Also swollen lymph nodes behind ears. Jan, 11, 2021 ( one week post vaccination)    4:00 AM  Injection site swollen, hard, red, hot, and painful. Lymph nodes all still swollen        and tender (sometimes painful).  CNP (in charge of infection control at my hospital), observed injection site and checked daily to be sure cellulitis was not developing where an antibiotic would be indicated. Jan, 14, 2021    Injection site redness is dissipating and inflammation is decreasing.  Running out of time.... Feb. 13,2021  Still swollen and painful lymph nodes.
This spontaneous report as received from a physician refers to a 45 year old male patient. The patient's concurrent conditions included migraines. The patient had none drug reactions/allergies or concomitant medications. On an unspecified date in July 2016, the patient was vaccinated with the first dose of RECOMBIVAX HB (Lot #, expiration date, Strength and dose were not reported), route of administration was unknown by the reporter. On an unspecified date in 2016 (reported as an unspecified amount of time after the dose was administered), the patient experienced fever, chills, diarrhea, body aches, itchy palms and itchy feet for a "few days", then the events resolved on an unspecified date in 2016. On an unspecified date in August 2016, the patient was vaccinated with the second dose of RECOMBIVAX HB Lot # reported as M033096, expiration date: 31-MAY-2018, (Strength and dose were not reported), route of administration was unknown by the reporter. On an unspecified date in 2016 (reported as an unspecified amount of time after the dose was administered), the patient experienced "diarrhea for two weeks causing a 12 pound weight loss", fever, chills, body aches, itchy palms and itchy feet, weakness, diminished appetite and depressed mood that had not resolved. The patient did not receive any treatment for the events. In addition, the following lab diagnostics tests were performed to the patient on unspecified dates in 2016 complete blood count (CBC) (results not provided), comprehensive metabolic panel (CMP) (results not provided). The physician considered the events to be disabling and he stated that because of the systemic reactions the patient was unable to work. The reporter did not provide the causality between RECOMBIVAX HB and the events. A product quality complaint was not involved. Additional information has been requested.
At 9 PM, day of injection (9:30 AM) while watching TV-felt tightness across chest with deep inspiration and radiated to left jaw. (same side of injection)-2 am-woke with pain (L) ear and teeth
Patient was supposed to receive the Pfizer 12+ Bivalent booster today, but received the Pfizer 12+ monovalent vaccine instead. Medical assistant accidentally pulled the wrong Pfizer vial. Patient's PCP, is aware of the situation. No harm to patient for receiving this vaccine.
Fever; Chills; Headache; Nausea; Racing heart; This is a spontaneous report from a contactable consumer. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12Apr2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. Concomitant medications included atenolol (MANUFACTURER UNKNOWN); from unknown date for unknown indication and unknown if on going. The patient had no known allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021, the patient experienced fever, chills, headache, nausea and racing heart. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. . The patient did not receive any treatment for the reported event. The clinical outcome of the events of fever, chills, headache, nausea and racing heart was recovering.   No follow-up attempts are possible. No further information is expected.
dark discoloration on the palm of his hand; looks like a bruise /covers the entire palm of his hand; This spontaneous case was reported by a pharmacist and describes the occurrence of SKIN DISCOLOURATION (dark discoloration on the palm of his hand) and CONTUSION (looks like a bruise /covers the entire palm of his hand) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced SKIN DISCOLOURATION (dark discoloration on the palm of his hand) and CONTUSION (looks like a bruise /covers the entire palm of his hand). At the time of the report, SKIN DISCOLOURATION (dark discoloration on the palm of his hand) and CONTUSION (looks like a bruise /covers the entire palm of his hand) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.
undertake a covid19 test and he tested positive; Chills; Headache; Muscle Cramps; Dry cough; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 01-May-2021. The most recent information was received on 02-May-2021 and was forwarded to Moderna on 02-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Muscle Cramps), COUGH (Dry cough), COVID-19 (undertake a covid19 test and he tested positive), CHILLS (Chills) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced MUSCLE SPASMS (Muscle Cramps), COUGH (Dry cough), CHILLS (Chills) and HEADACHE (Headache). On 02-May-2021, the patient experienced COVID-19 (undertake a covid19 test and he tested positive). On 01-May-2021, MUSCLE SPASMS (Muscle Cramps), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, COUGH (Dry cough) had not resolved and COVID-19 (undertake a covid19 test and he tested positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-May-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: Reporter information, additional events and lab data were updated On 02-May-2021: No new information was provided.
symptoms came on suddenly and started getting worse and worse, horrible itching inside nose, horrible itching back of throat,pain on injection site, nose started running with clear discharge. I took 1 benadryl 25 mg at 9 PM, took another one 10:30 pm . Still having worsening itching  and I started to cough. Took a 20 mg prednisone at 11PM, took a second 20mg prednisone at 12:53. Now my eyes starting to itch and  my gums are itchy too. If symptoms don't subside I will be taking myself to the ER.
Information has been received from a pharmacist concerning a 60 year old female patient. There were no drug reactions and allergies. No pertinent medical history or concurrent conditions were reported. On 21-SEP-2016, the patient was vaccinated with an unspecified dose of ZOSTAVAX at a dose of 65 ml, via subcutaneous route (the frequency was reported as "once") (lot number reported as M026874 with an expiration date of 19-JUL-2017) (strength and anatomical location were not reported). Concomitant therapies included ramipril, AMBIEN, ZANTAC, EFFEXOR, COREG, MIRALAX, PRILOSEC, KLONOPIN and CRESTOR. Other suspect medications were not reported. On 22-SEP-2016 the patient developed redness and itchiness at the ZOSTAVAX injection site, which was also swollen (injection site erythema, injection site swelling and injection site pruritus). On unspecified date in 2016, the patient sought medical attention and she was seen by an unspecified physician in regards to the reaction and was prescribed BACTRIM DS as treatment for the reaction. Laboratory diagnostic studies were not performed. No product quality complaint was involved. At the time of reporting, the outcome of injection site erythema, injection site swelling and injection site pruritus was unknown. The relatedness between the events and therapy with ZOSTAVAX was not reported. Additional information has been requested.
Mom states childs left arm turning red and swollen after injection around injection site and spreading around arm. Hot to touch and painful. Mom states child seen in ER before notifying office of reaction. States was told to take Benadryl and Tylenol advised by vaccine administrator to take ibuprofen and Benadryl and to seek MD care due to mom stating child had had cellulitis before and did not recover without meds. Mom states would call MD ASAP.
Of course left arm sore for a couple of days which I think was standard.  Within a few hours of the vaccine, numerous ulcers developed in my mouth and have just basically cleared up.  Some minor issues with digestion resulting in (sorry for the following description) increased "stinky" gas, constipation and darker than usual pasty poop which is not normal for me.  This too is leveling out and getting back to normal.  Besides some slight initial head aches and weak legs it appears all may be back to close to normal.
Initially had chills, fatigue for two days, then on 3/15 awoke with severe weakness in the right lower extremity. Presented to ER, MRI showed acute stroke ( Small acute infarction within the posterior left corona radiata). Admitted for stroke stabilization and rehab evaluation. Will be discharged to home with outpatient PT and OT
Coughed wet mucus from 3-5p, then onset of headache that lasted overnight into the morning. Head was heavy. Nausea, but never actually threw up, Both sides where kidney's are located felt like someone punched me. All over achy, Temp-99.5 around 9p when checked, took Advil before bed at 9p, slight nausea lasted into midday the next day.
Patient complained of throat burning and burning lips, the left side of her face was burning & numb. She felt she could not control the muscles in left side of face.
patient experienced a pulmonary embolism Date of diagnosis: 4Aug2022; This spontaneous case was reported by a patient and describes the occurrence of PULMONARY EMBOLISM (patient experienced a pulmonary embolism Date of diagnosis: 4Aug2022) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056m21a, 032f21a, 0391520a and 026l20a) for COVID-19 vaccination.     Concomitant products included METOPROLOL, AMLODIPINE, ALBUTEROL [SALBUTAMOL] and LORAZEPAM (ATIVAN) for an unknown indication.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Aug-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PULMONARY EMBOLISM (patient experienced a pulmonary embolism Date of diagnosis: 4Aug2022) (seriousness criteria hospitalization and medically significant). At the time of the report, PULMONARY EMBOLISM (patient experienced a pulmonary embolism Date of diagnosis: 4Aug2022) was resolving.            No treatment medications was reported. The patient did not have any COVID positive test or diagnosis.  Company Comment: This spontaneous case concerns a 48-year-old female patient with no medical history reported, who experienced the unexpected serious (hospitalization and medically significant) AESI of Pulmonary embolism which occurred 2 months 11 days after the fourth dose of mRNA-1273 vaccine in covid-19 vaccination series. No further information on clinical course, investigations and treatment received was available in the report. The outcome of the event was reported as resolving. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.   This case was linked to MOD-2021-005478 (Patient Link).; Sender's Comments: This spontaneous case concerns a 48-year-old female patient with no medical history reported, who experienced the unexpected serious (hospitalization and medically significant) AESI of Pulmonary embolism which occurred 2 months 11 days after the fourth dose of mRNA-1273 vaccine in covid-19 vaccination series. No further information on clinical course, investigations and treatment received was available in the report. The outcome of the event was reported as resolving. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.
After a full course of Paxlovid, I began to experience COVID symptoms again and test positive on an at-home test.; After a full course of Paxlovid, I began to experience COVID symptoms again and test positive on an at-home test.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old male patient received BNT162b2 (BNT162B2), on 09Oct2021 at 16:15 as dose 3 (booster), single (Lot number: ER8730) at the age of 39 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: CETIRIZINE HYDROCHLORIDE, start date: 01Nov2020, stop date: 08May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 05May2022 at 22:00, outcome "not recovered" and all described as "After a full course of Paxlovid, I began to experience COVID symptoms again and test positive on an at-home test.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) positive, notes: I began to experience COVID symptoms again and test positive on an at-home test. Therapeutic measures were taken as a result of drug ineffective, covid-19.The patient was treated with Antiviral drug for Covid 19 from 27th April 2022 to 02 May 2022).  No follow-up attempts are possible. No further information is expected.
Information has been received from a Registered Nurse referring to an 8 week old patient of unknown gender. Information about patient's concurrent conditions and medical history was not reported. On 25-JUN-2015 the patient was vaccinated with a dose of improperly stored PEDVAXHIB (route not reported, lot # reported as K026532, dose 0.5 (unit not provided). Concomitant medications were not provided. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
For over the past week, I have had hives everyday, and anaphylaxis episodes after most meals.  I?ve been to the ER and am scheduled for allergy testing.  I believe my Modena vaccines kicked my Hashimoto disease into over drive.
Box 17 - Shingrix   Soreness and tenderness at injection site for several days. Severe aching in neck muscles, elbows, hips and artificial knees. Swelling and inflammation at right foot. No medical attention sought. Slight nausea, recovered in 72 hours. Aches/pains resolved in 4-6 days. Right foot normal as of two days ago.